SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001773427-23-000029
Filing Date
2023-08-02
Accepted
2023-08-02 06:36:04
Documents
50
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q swtx-20230630.htm   iXBRL 10-Q 826703
2 EX-31.1 swtx-20230630xex311.htm EX-31.1 11383
3 EX-31.2 swtx-20230630xex312.htm EX-31.2 11402
4 EX-32.1 swtx-20230630xex321.htm EX-32.1 5564
5 EX-32.2 swtx-20230630xex322.htm EX-32.2 5570
  Complete submission text file 0001773427-23-000029.txt   3950513

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT swtx-20230630.xsd EX-101.SCH 24839
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT swtx-20230630_cal.xml EX-101.CAL 50219
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT swtx-20230630_def.xml EX-101.DEF 108564
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT swtx-20230630_lab.xml EX-101.LAB 373146
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT swtx-20230630_pre.xml EX-101.PRE 221310
44 EXTRACTED XBRL INSTANCE DOCUMENT swtx-20230630_htm.xml XML 467952
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39044 | Film No.: 231133632
SIC: 2836 Biological Products, (No Diagnostic Substances)